Labeler
Hikma Pharmaceuticals USA Inc. NDC Codes
Hikma Pharmaceuticals USA Inc. lists 759 finished drug products in the FDA NDC Directory under NDC labeler codes 0054, 0143, 0641, 24201.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tapentadol, Ropivacaine Hydrochloride, Tyzavan, Daptomycin, Deflazacort, Lithium Carbonate, Eltrombopag, Cefepime Hydrochloride, Starjemza, Gemcitabine, Vancomycin Hydrochloride, dicyclomine hydrochloride, Meropenem, Atropine Sulfate, Fentanyl Citrate
- Active ingredients
- Tapentadol hydrochloride, Ropivacaine hydrochloride, Vancomycin, Daptomycin, Deflazacort, Lithium carbonate, Eltrombopag olamine, Cefepime hydrochloride, Ustekinumab, Gemcitabine hydrochloride, Vancomycin hydrochloride, Polymyxin b sulfate
- NDC labeler codes
- 0054, 0143, 0641, 24201
- Strengths (from the 100 most recently listed products)
- Daptomycin 500 mg/10mL; Ropivacaine hydrochloride 2 mg/mL; Gemcitabine hydrochloride 38 mg/mL; Lithium carbonate 300 mg/1; Daptomycin 350 mg/7mL; Tapentadol hydrochloride 50 mg/1; Tapentadol hydrochloride 100 mg/1; Ropivacaine hydrochloride 5 mg/mL; Cefepime hydrochloride 1 g/1; Cefepime hydrochloride 2 g/1; Ustekinumab 45 mg/.5mL; Fentanyl citrate 50 ug/mL; Glycopyrrolate .2 mg/mL; Mercaptopurine 20 mg/mL; Neomycin sulfate 3.5 mg/mL; Polymyxin b sulfate 10000 [iU]/mL; Hydrocortisone 10 mg/mL; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1
- Dosage forms
- Injection, Injection, Solution, Injection, Powder, For solution, Tablet, Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Extended release, Tablet, Film coated, Capsule, Capsule, Gelatin coated, Solution, Suspension, Solution/ drops, Liquid, Injection, Suspension
- Routes
- Intravenous, Oral, Intramuscular, Subcutaneous, Epidural, Infiltration, Perineural, Auricular (Otic), Intravascular, Intrathecal, Ophthalmic, Intra-articular
- Drug classes (FDA established)
- Opioid Agonist, Glycopeptide Antibacterial, Amide Local Anesthetic, Corticosteroid, Anticholinergic, Lipopeptide Antibacterial, Nucleoside Metabolic Inhibitor, Mood Stabilizer, Thrombopoietin Receptor Agonist, Cholinergic Muscarinic Antagonist, Cephalosporin Antibacterial, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Polymyxin-class Antibacterial, Penem Antibacterial, RANK Ligand Inhibitor, Serotonin-4 Receptor Agonist, Antiarrhythmic, Progesterone, Nondepolarizing Neuromuscular Blocker, Aminoglycoside Antibacterial, Cholinergic Receptor Agonist, Benzodiazepine, Catecholamine, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Janus Kinase Inhibitor, Antidote, Antidote for Acetaminophen Overdose, Mucolytic, Central alpha-2 Adrenergic Agonist, Prostaglandin Analog, Phenylalanine Hydroxylase Activator, Atypical Antipsychotic, beta-Adrenergic Blocker, Opioid Antagonist, Oxidation-Reduction Agent
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J0897 — Injection, denosumab, 1 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg
- Package NDCs
- 110 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Methotrexate | Methotrexate 25 mg/mL | SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | 0143-9519 | 00143-9519-10 | — |
| Ceftriaxone | Ceftriaxone sodium 10 g/1 | Injection, Powder, For solutionIntravenous | 0143-9678 | 00143-9678-01 | J0696 |
| Pantoprazole Sodium | Pantoprazole sodium 40 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9284 | 00143-9284-10 | — |
| Pantoprazole Sodium | Pantoprazole sodium 40 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9300 | 00143-9300-10 | — |
| Dihydroergotamine Mesylate | Dihydroergotamine mesylate 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0143-9273 | 00143-9273-10 | — |
| Desvenlafaxine | Desvenlafaxine succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | 0054-0603 | 00054-0603-13 | — |
| Dantrolene | Dantrolene sodium 20 mg/1 | Injection, Powder, For solutionIntravenous | 0143-9297 | 00143-9297-01 | — |
| Ifosfamide | Ifosfamide 50 mg/mL | InjectionIntravenous | 0143-9530 | 00143-9530-01 | — |
| Ifosfamide | Ifosfamide 50 mg/mL | InjectionIntravenous | 0143-9531 | 00143-9531-01 | — |
| Rocuronium Bromide | Rocuronium bromide 10 mg/mL | InjectionIntravenous | 0143-9250 | 00143-9250-10 | — |
| Rocuronium Bromide | Rocuronium bromide 10 mg/mL | InjectionIntravenous | 0143-9251 | 00143-9251-10 | — |
| Dexmedetomidine HCl | Dexmedetomidine hydrochloride 100 ug/mL | InjectionIntravenous | 0143-9532 | 00143-9532-25 | — |
| Desvenlafaxine | Desvenlafaxine succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | 0054-0400 | 00054-0400-1300054-0400-22 | — |
| Desvenlafaxine | Desvenlafaxine succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | 0054-0401 | 00054-0401-1300054-0401-22 | — |
| Idarubicin Hydrochloride | Idarubicin hydrochloride 1 mg/mL | Injection, SolutionIntravenous | 0143-9217 | 00143-9217-01 | — |
| Idarubicin Hydrochloride | Idarubicin hydrochloride 1 mg/mL | Injection, SolutionIntravenous | 0143-9218 | 00143-9218-01 | — |
| Idarubicin Hydrochloride | Idarubicin hydrochloride 1 mg/mL | Injection, SolutionIntravenous | 0143-9219 | 00143-9219-01 | — |
| Methamphetamine Hydrochloride | Methamphetamine hydrochloride 5 mg/1 | TabletOral | 0054-0389 | 00054-0389-25 | — |
| Argatroban | Argatroban 50 mg/50mL | InjectionIntravenous | 0143-9559 | 00143-9559-01 | — |
| Amoxicillin and Clavulanate Potassium | Amoxicillin 875 mg/1; Clavulanate potassium 125 mg/1 | TabletOral | 0143-9249 | 00143-9249-20 | — |
| Levoleucovorin | Levoleucovorin calcium 50 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9558 | 00143-9558-01 | — |
| Nicardipine Hydrochloride | Nicardipine hydrochloride .2 mg/mL | InjectionIntravenous | 0143-9633 | 00143-9633-10 | — |
| Nicardipine Hydrochloride | Nicardipine hydrochloride .1 mg/mL | InjectionIntravenous | 0143-9634 | 00143-9634-10 | — |
| Rifampin | Rifampin 600 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9230 | 00143-9230-01 | — |
| Acyclovir | Acyclovir sodium 500 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9657 | 00143-9657-10 | — |
| Acyclovir | Acyclovir sodium 1 g/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9658 | 00143-9658-10 | — |
| Etomidate | Etomidate 2 mg/mL | InjectionIntravenous | 0143-9310 | 00143-9310-10 | — |
| Etomidate | Etomidate 2 mg/mL | InjectionIntravenous | 0143-9311 | 00143-9311-10 | — |
| Etomidate | Etomidate 2 mg/mL | InjectionIntravenous | 0143-9506 | 00143-9506-10 | — |
| Etomidate | Etomidate 2 mg/mL | InjectionIntravenous | 0143-9507 | 00143-9507-10 | — |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 500 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9850 | 00143-9850-01 | — |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9851 | 00143-9851-01 | — |
| Dicyclomine Hydrochloride | Dicyclomine hydrochloride 10 mg/mL | InjectionIntramuscular | 0641-6173 | 00641-6173-10 | — |
| Neostigmine Methylsulfate | Neostigmine methylsulfate 1 mg/mL | InjectionIntravenous | 0641-6149 | 00641-6149-10 | — |
| Neostigmine Methylsulfate | Neostigmine methylsulfate .5 mg/mL | InjectionIntravenous | 0641-6150 | 00641-6150-10 | — |
| Neostigmine Methylsulfate | Neostigmine methylsulfate .5 mg/mL | InjectionIntravenous | 0641-6264 | 00641-6264-10 | — |
| Neostigmine Methylsulfate | Neostigmine methylsulfate 1 mg/mL | InjectionIntravenous | 0641-6265 | 00641-6265-10 | — |
| Neostigmine Methylsulfate | Neostigmine methylsulfate 1 mg/mL | InjectionIntravenous | 0641-6277 | 00641-6277-10 | — |
| Sterile Waterwater | Water 1 mL/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | 0641-6147 | 00641-6147-1000641-6147-25 | — |
| Amikacin Sulfate | Amikacin sulfate 250 mg/mL | InjectionIntramuscular, Intravenous | 0641-6166 | 00641-6166-10 | — |
| Amikacin Sulfate | Amikacin sulfate 250 mg/mL | InjectionIntramuscular, Intravenous | 0641-6167 | 00641-6167-10 | — |
| Linezolid | Linezolid 100 mg/5mL | Powder, For suspensionOral | 0054-0319 | 00054-0319-50 | — |
| Morphine Sulfate | Morphine sulfate 4 mg/mL | InjectionIntravenous | 0641-6125 | 00641-6125-25 | — |
| Morphine Sulfate | Morphine sulfate 8 mg/mL | InjectionIntravenous | 0641-6126 | 00641-6126-25 | — |
| Morphine Sulfate | Morphine sulfate 10 mg/mL | InjectionIntravenous | 0641-6127 | 00641-6127-25 | — |
| Levetiracetam | Levetiracetam 100 mg/mL | InjectionIntravenous | 0143-9574 | 00143-9574-1000143-9574-25 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | 0143-9584 | 00143-9584-10 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | 0143-9585 | 00143-9585-25 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | 0143-9586 | 00143-9586-25 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | 0143-9587 | 00143-9587-25 | — |
Hikma Pharmaceuticals USA Inc.: common questions
- What is Hikma Pharmaceuticals USA Inc.'s NDC labeler code?
- 0054, 0143, 0641, 24201. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Hikma Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J0171, J0897, J3357 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.